What is the Valiant Laboratories Ltd share price today?

The share price of NSE:VALIANTLAB-BE on 01 Oct 2026 (as of 15:05:11 IST) is ₹125.7.

What is the NSE:VALIANTLAB-BE 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:VALIANTLAB-BE 52 week high low range shows a high of ₹132.25 and a low of ₹49.51.

What is the Valiant Laboratories Ltd market cap?

As on 01 Oct 2026, Valiant Laboratories Ltd market cap is ₹6873250000.

What is the shareholding pattern of Valiant Laboratories Ltd Stock?

The shareholding pattern of Valiant Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 74.94% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 25.06% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Valiant Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd is 52.0188, and the Price-to-Book (PB) ratio is 1.424, as on 01 Oct 2026.

Valiant Laboratories Share Price

123.33-2.51 (-1.99%)

+47.31% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.99%

1 Week

-3.95%

1 Month

-1.00%

3 Month

+100.47%

6 Month

+55.90%

YTD

+76.19%

1 Year

+47.31%

5 Year

10 Year

Max

-18.11%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

123.33

113.00

61.00

58.08

49.51

High

123.33

128.60

141.38

About

Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

VALIANTLAB-BENSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

123.33-5 (-3.90%)

123.33

130.88

684Cr

Valiant Laboratories Share Price

123.33-2.51 (-1.99%)

+47.31% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-11%

Last year78%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-48%

Stock Price CAGR

10 years-

5 years-

3 years-12%

1 year47%

Return on Equity

10 years7%

5 years7%

3 years-1%

Last year-1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-11%	78%
-	-	-	-48%
-	-	-12%	47%
7%	7%	-1%	-1%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

VALIANTLAB-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
123.33	₹684 Cr	42.76	3.89	4.49	-₹3 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
₹117 Cr	₹115 Cr	₹92 Cr	₹52 Cr	₹46 Cr	₹47 Cr	₹58 Cr	₹35 Cr	₹21 Cr	₹19 Cr	₹31 Cr	₹41 Cr	₹60 Cr	₹51 Cr	₹90 Cr	₹71 Cr	₹88 Cr
₹11 L	₹86 L	₹17 L	₹63 L	₹87 L	₹66 L	-₹2 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹78 L	₹1 Cr
₹117 Cr	₹116 Cr	₹92 Cr	₹53 Cr	₹47 Cr	₹47 Cr	₹55 Cr	₹37 Cr	₹25 Cr	₹22 Cr	₹33 Cr	₹42 Cr	₹63 Cr	₹54 Cr	₹92 Cr	₹72 Cr	₹89 Cr
₹115 Cr	₹89 Cr	₹90 Cr	₹55 Cr	₹47 Cr	₹45 Cr	₹54 Cr	₹35 Cr	₹29 Cr	₹22 Cr	₹36 Cr	₹47 Cr	₹61 Cr	₹48 Cr	₹82 Cr	₹61 Cr	₹78 Cr
₹5 Cr	₹30 Cr	₹5 Cr	-₹26 L	₹95 L	₹3 Cr	₹2 Cr	₹2 Cr	-₹3 Cr	₹43 L	-₹2 Cr	-₹5 Cr	₹2 Cr	₹6 Cr	₹10 Cr	₹11 Cr	₹12 Cr
₹96 L	₹1 Cr	₹1 Cr	₹68 L	₹14 L	₹7 L	₹6 L	₹6 L	₹60,000	₹5 L	₹2 L	₹2 L	₹2 L	₹2 L	₹3 L	₹4 L	₹17 L
₹67 L	₹26 Cr	₹1 Cr	-₹3 Cr	₹28 L	₹2 Cr	₹94 L	₹2 Cr	-₹4 Cr	-₹16 L	-₹3 Cr	-₹5 Cr	₹1 Cr	₹6 Cr	₹10 Cr	₹10 Cr	₹12 Cr
₹42 L	₹21 Cr	₹2 Cr	-₹7 Cr	₹20 L	₹2 Cr	₹70 L	₹2 Cr	-₹5 Cr	-₹51 L	-₹1 Cr	-₹4 Cr	₹79 L	₹4 Cr	₹8 Cr	₹8 Cr	₹9 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023
—	—	—	—
₹54 Cr	₹43 Cr	₹43 Cr	₹33 Cr
₹257 Cr	₹191 Cr	₹193 Cr	₹68 Cr
₹257 Cr	₹191 Cr	₹193 Cr	₹68 Cr
₹311 Cr	₹234 Cr	₹237 Cr	₹100 Cr
₹28 Cr	₹45 Cr	₹15 Cr	₹0
₹0	₹59 Cr	₹59 Cr	₹59 Cr
₹4 Cr	₹1 Cr	₹62 L	₹67 L
₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr
₹15 L	₹13 L	₹8 L	₹8 L
₹34 Cr	₹107 Cr	₹77 Cr	₹62 Cr
—	—	—	—
₹94 Cr	₹41 Cr	₹26 Cr	₹47 Cr
₹8 Cr	₹2 Cr	₹2 Cr	₹3 Cr
₹17 Cr	₹17 Cr	₹1 Cr	₹0
₹32 L	₹20 L	₹12 L	₹12 L
₹119 Cr	₹60 Cr	₹29 Cr	₹51 Cr
₹464 Cr	₹401 Cr	₹343 Cr	₹213 Cr
₹49 Cr	₹62 Cr	₹3 L	₹3 L
₹45 Cr	₹121 Cr	₹76 Cr	₹59 Cr
—	—	—	—
₹255 Cr	₹71 Cr	₹70 Cr	₹66 Cr
₹28 Cr	₹22 Cr	₹20 Cr	₹18 Cr
₹227 Cr	₹48 Cr	₹50 Cr	₹48 Cr
₹6 Cr	₹156 Cr	₹43 Cr	₹68 L
₹2 Cr	₹4 Cr	₹24 Cr	₹14 Cr
₹3 L	₹0	₹0	₹0
₹236 Cr	₹208 Cr	₹117 Cr	₹62 Cr
—	—	—	—
₹26 Cr	₹0	₹38 Cr	₹34 Cr
₹45 Cr	₹4 Cr	₹10 Cr	₹13 Cr
₹94 Cr	₹72 Cr	₹46 Cr	₹89 Cr
₹7 Cr	₹76 Cr	₹106 Cr	₹1 Cr
₹5 Cr	₹81 L	₹2 Cr	₹1 Cr
₹51 Cr	₹40 Cr	₹24 Cr	₹12 Cr
₹228 Cr	₹193 Cr	₹226 Cr	₹151 Cr
₹109 Cr	₹133 Cr	₹196 Cr	₹100 Cr
₹464 Cr	₹401 Cr	₹343 Cr	₹213 Cr
₹57	₹54	₹55	₹31
₹57	₹50	₹51	₹31

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023
₹77 L	-₹2 Cr	-₹77 L	₹38 Cr
₹7 Cr	₹4 Cr	₹2 Cr	₹2 Cr
-₹17 Cr	-₹4 Cr	-₹37 L	₹25 Cr
-₹9 Cr	-₹1 Cr	₹90 L	₹65 Cr
-₹10 Cr	₹1 Cr	₹2 Cr	₹56 Cr
₹7 Cr	-₹53 Cr	-₹144 Cr	-₹55 Cr
₹2 Cr	₹45 Cr	₹152 Cr	-₹93 L
-₹1 Cr	-₹7 Cr	₹10 Cr	-₹5 L
₹5 Cr	₹12 Cr	₹1 Cr	₹1 Cr
₹4 Cr	₹5 Cr	₹12 Cr	₹1 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Valiant Laboratories Share Price

123.33-2.51 (-1.99%)

+47.31% past 1 Year

Shareholding summary

Promoters

74.94%

FII

0.07%

DII

0.08%

Others

24.91%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
74.94%	74.94%	74.94%	74.94%	74.94%	74.94%
0.07%	0.00%	0.20%	0.01%	0.02%	0.63%
0.08%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
24.91%	25.06%	24.86%	25.05%	25.04%	24.43%

Bulk & block deals

Name

Metasoni Alloys Pvt Ltd

Trade Corner

Necta Bloom Vcc - Necta Bloom One

Marwadi Chandarana Intermediaries Brokers Private Limited

Money Logix Securities Pvt Ltd

Jainam Broking Limited

Jaliyan Commodity

Jainam Broking Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
17 Dec 2025	Purchase	2.10 Cr	₹67.33	3.12 L	Bulk	0.574452	NSE
17 Dec 2025	Sell	5.19 L	₹66.98	7.74 K	Bulk	0.014255	NSE
13 Jun 2025	Sell	2.83 Cr	₹120.29	2.35 L	Bulk	0.433049	NSE
31 Jan 2025	Purchase	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
31 Jan 2025	Sell	2.83 Cr	₹102.75	2.75 L	Bulk	0.506329	NSE
24 Jan 2025	Purchase	5.82 Cr	₹105.78	5.50 L	Bulk	1.012658	NSE
24 Jan 2025	Sell	5.82 Cr	₹105.77	5.50 L	Bulk	1.012658	NSE
07 Jun 2024	Sell	4.92 Cr	₹142.80	3.44 L	Bulk	0.634071	NSE
07 Jun 2024	Purchase	4.99 Cr	₹142.81	3.49 L	Bulk	0.642841	NSE
07 Jun 2024	Purchase	18.27 L	₹148.54	12.30 K	Bulk	0.022647	NSE

Insider trading & SAST

Client name

Valiant Organics Ltd

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Jun 2026	Promoter	Acquisition	34.26	—	0	—	1.86 Cr	01 Jan 1900	—	—	SAST	10(5)	—

Valiant Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Valiant Laboratories Share Price

Valiant Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Valiant Laboratories Share Price

Valiant Laboratories Share Price

Oscillators

Moving averages

Valiant Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Valiant Laboratories Share Price

Corporate Actions

Company details

Valiant Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Valiant Laboratories Share Price

News

Valiant Laboratories QC Manager Bhanudas D. Patil Resigns for Personal Reasons Effective April 22, 2026.

Valiant Laboratories - Quaterly Results

Valiant Laboratories reports Profit after tax of 3.30 Lakhs, in the December 2025 quarter

Valiant Laboratories reports Profit after tax of 16.80 Lakhs, in the September 2025 quarter

Valiant Laboratories informs about scrutinizers report

Valiant Laboratories reports Profit after tax of 1.82 Crores, in the June 2025 quarter

Valiant Laboratories - Quaterly Results

Valiant Laboratories - Quaterly Results

Valiant Laboratories - Quaterly Results

Valiant Laboratories informs about credit rating

Valiant Laboratories informs about credit ratings

Valiant Laboratories - Quaterly Results

Valiant Laboratories reports Profit after tax of 1.60 Crores, in the December 2024 quarter

Valiant Laboratories - Quaterly Results

Valiant Laboratories - Quaterly Results

Valiant Laboratories informs about voting results of postal ballot

Valiant Laboratories reports Profit after tax of Rs -5.98 Crores, in the September 2024 quarter

Valiant Laboratories informs about credit rating

Valiant Laboratories informs about newspaper publication

Valiant Laboratories - Quaterly Results

Valiant Laboratories Ltd Share Price Today

Valiant Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator